National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
NCI Drug Dictionary
Page Options
Print This Page
More NCI Dictionaries
Dictionary of Cancer Terms

Glossary of Statistical Terms

NCI Dictionary of Genetics Terms

Terminology Resources
Quit Smoking Today
Search for
# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z All

recombinant interleukin-4
A recombinant therapeutic agent which is chemically identical to or similar to the endogenous cytokine interleukin-4 (IL-4). Produced primarily by activated T-cells, IL-4 binds to and activates its cell-surface receptor, stimulating the proliferation and differentiation of activated B-cells and enhancing their ability to present antigens to T-cells. As a potential immunotherapeutic agent, recombinant IL-4 also augments the effects of other cytokines on dendritic cells (DC), cytotoxic T lymphocytes (CTL), and tumor-infiltrating lymphocytes (TIL). Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Synonyms:B Cell Proliferating Factor
B-Cell Growth Factor
B-Cell Stimulating Factor
B-Cell Stimulatory Factor 1
Mast Cell Growth Factor-2
recombinant human IL-4
T-Cell Growth Factor 2
Abbreviations:BCGF
BCSF 1
IL-4
MCGF 2
rhIL-4



Previous:recombinant interleukin-1-beta, recombinant interleukin-11, recombinant interleukin-12, recombinant interleukin-18, recombinant interleukin-3
Next:recombinant interleukin-6, recombinant interleukin-7, recombinant macrophage colony-stimulating factor, recombinant MAGE-3.1 antigen, recombinant MAGE-A3 antigen-specific cancer immunotherapeutic GSK1203486A

A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov